Logo image of CTKB

CYTEK BIOSCIENCES INC (CTKB) Stock Overview

USA - NASDAQ:CTKB - US23285D1090 - Common Stock

4.1 USD
-0.01 (-0.24%)
Last: 10/23/2025, 1:37:08 PM

CTKB Key Statistics, Chart & Performance

Key Statistics
Market Cap521.60M
Revenue(TTM)196.03M
Net Income(TTM)-6401000
Shares127.22M
Float115.42M
52 Week High7.63
52 Week Low2.37
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.05
PEN/A
Fwd PEN/A
Earnings (Next)11-11 2025-11-11/amc
IPO2021-07-23
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


CTKB short term performance overview.The bars show the price performance of CTKB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20

CTKB long term performance overview.The bars show the price performance of CTKB in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of CTKB is 4.1 USD. In the past month the price increased by 20.53%. In the past year, price decreased by -12.37%.

CYTEK BIOSCIENCES INC / CTKB Daily stock chart

CTKB Latest News, Press Relases and Analysis

CTKB Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.41 214.95B
DHR DANAHER CORP 28.78 158.88B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 147.87 48.23B
A AGILENT TECHNOLOGIES INC 27.04 41.79B
IQV IQVIA HOLDINGS INC 19.31 37.66B
MTD METTLER-TOLEDO INTERNATIONAL 34.69 29.23B
WAT WATERS CORP 28.94 21.07B
WST WEST PHARMACEUTICAL SERVICES 44.28 22.16B
MEDP MEDPACE HOLDINGS INC 42.13 16.92B
ICLR ICON PLC 13.66 14.01B
ILMN ILLUMINA INC 23.92 15.29B
TEM TEMPUS AI INC N/A 15.24B

About CTKB

Company Profile

CTKB logo image Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. The company is headquartered in Fremont, California and currently employs 688 full-time employees. The company went IPO on 2021-07-23. The firm is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Company Info

CYTEK BIOSCIENCES INC

47215 Lakeview Boulevard

Fremont CALIFORNIA US

Employees: 688

CTKB Company Website

CTKB Investor Relations

Phone: 18779229835

CYTEK BIOSCIENCES INC / CTKB FAQ

What is the stock price of CYTEK BIOSCIENCES INC today?

The current stock price of CTKB is 4.1 USD. The price decreased by -0.24% in the last trading session.


What is the ticker symbol for CYTEK BIOSCIENCES INC stock?

The exchange symbol of CYTEK BIOSCIENCES INC is CTKB and it is listed on the Nasdaq exchange.


On which exchange is CTKB stock listed?

CTKB stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for CYTEK BIOSCIENCES INC stock?

11 analysts have analysed CTKB and the average price target is 5.23 USD. This implies a price increase of 27.5% is expected in the next year compared to the current price of 4.1. Check the CYTEK BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CYTEK BIOSCIENCES INC worth?

CYTEK BIOSCIENCES INC (CTKB) has a market capitalization of 521.60M USD. This makes CTKB a Small Cap stock.


How many employees does CYTEK BIOSCIENCES INC have?

CYTEK BIOSCIENCES INC (CTKB) currently has 688 employees.


What are the support and resistance levels for CYTEK BIOSCIENCES INC (CTKB) stock?

CYTEK BIOSCIENCES INC (CTKB) has a support level at 3.94 and a resistance level at 4.16. Check the full technical report for a detailed analysis of CTKB support and resistance levels.


Is CYTEK BIOSCIENCES INC (CTKB) expected to grow?

The Revenue of CYTEK BIOSCIENCES INC (CTKB) is expected to decline by -3.3% in the next year. Check the estimates tab for more information on the CTKB EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CYTEK BIOSCIENCES INC (CTKB) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CYTEK BIOSCIENCES INC (CTKB) stock pay dividends?

CTKB does not pay a dividend.


When does CYTEK BIOSCIENCES INC (CTKB) report earnings?

CYTEK BIOSCIENCES INC (CTKB) will report earnings on 2025-11-11, after the market close.


What is the Price/Earnings (PE) ratio of CYTEK BIOSCIENCES INC (CTKB)?

CYTEK BIOSCIENCES INC (CTKB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).


What is the Short Interest ratio of CYTEK BIOSCIENCES INC (CTKB) stock?

The outstanding short interest for CYTEK BIOSCIENCES INC (CTKB) is 4.95% of its float. Check the ownership tab for more information on the CTKB short interest.


CTKB Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to CTKB. When comparing the yearly performance of all stocks, CTKB is a bad performer in the overall market: 65.17% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CTKB Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to CTKB. No worries on liquidiy or solvency for CTKB as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CTKB Financial Highlights

Over the last trailing twelve months CTKB reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS increased by 45.05% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1.3%
ROE -1.7%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%-2.18%
EPS 1Y (TTM)45.05%
Revenue 1Y (TTM)-0.85%

CTKB Forecast & Estimates

11 analysts have analysed CTKB and the average price target is 5.23 USD. This implies a price increase of 27.5% is expected in the next year compared to the current price of 4.1.

For the next year, analysts expect an EPS growth of -308% and a revenue growth -3.3% for CTKB


Analysts
Analysts78.18
Price Target5.23 (27.56%)
EPS Next Y-308%
Revenue Next Year-3.3%

CTKB Ownership

Ownership
Inst Owners63.24%
Ins Owners9.23%
Short Float %4.95%
Short Ratio5.63